We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$6.22B
AUM Growth
+$1.63B
Cap. Flow
+$1.01B
Cap. Flow %
16.29%
Top 10 Hldgs %
50.83%
Holding
873
New
257
Increased
437
Reduced
93
Closed
84

Sector Composition

Rank Sector Weight
1 Financials 14.03%
2 Technology 8.61%
3 Healthcare 5.77%
4 Real Estate 3.85%
5 Energy 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEI.A icon
551
HEICO Corp Class A
HEI.A
$36B
$984K 0.02%
11,706
+1,784
+18% +$131K
BKU icon
552
Bankunited
BKU
$3.33B
$981K 0.02%
29,360
+4,687
+19% +$162K
LBTYK icon
553
Liberty Global Class C
LBTYK
$3.5B
$974K 0.02%
40,240
+2,818
+8% +$66.8K
CTMX icon
554
CytomX Therapeutics
CTMX
$690M
$973K 0.02%
+90,495
New +$1.34M
THG icon
555
Hanover Insurance
THG
$8.13B
$973K 0.02%
8,525
+1,168
+16% +$134K
RARX
556
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$972K 0.02%
+43,396
New +$933K
LBTYA icon
557
Liberty Global Class A
LBTYA
$3.59B
$971K 0.02%
38,953
+2,914
+8% +$71.2K
EQH icon
558
Equitable Holdings
EQH
$13.2B
$968K 0.02%
48,073
+13,710
+40% +$262K
TCBI icon
559
Texas Capital Bancshares
TCBI
$4.28B
$968K 0.02%
17,728
-5,507
-24% -$319K
HXL icon
560
Hexcel
HXL
$7.97B
$936K 0.02%
13,532
+1,889
+16% +$127K
ABT icon
561
Abbott
ABT
$187B
$928K 0.01%
+11,611
New +$864K
AGO icon
562
Assured Guaranty
AGO
$3.73B
$928K 0.01%
20,888
+2,864
+16% +$119K
DRNA
563
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$926K 0.01%
+63,242
New +$727K
GTHX
564
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$925K 0.01%
+55,719
New +$1.06M
TOL icon
565
Toll Brothers
TOL
$14B
$922K 0.01%
25,474
-6,070
-19% -$218K
STML
566
DELISTED
Stemline Therapeutics, Inc.
STML
$921K 0.01%
+71,658
New +$810K
BOH icon
567
Bank of Hawaii
BOH
$3.14B
$914K 0.01%
11,592
+2,604
+29% +$204K
PGNX
568
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$910K 0.01%
+196,017
New +$887K
AXS icon
569
AXIS Capital
AXS
$7.73B
$905K 0.01%
16,517
+2,264
+16% +$125K
FOXA icon
570
Fox Class A
FOXA
$24.8B
$904K 0.01%
+24,633
New +$960K
RIGL icon
571
Rigel Pharmaceuticals
RIGL
$723M
$904K 0.01%
+35,170
New +$804K
COR
572
DELISTED
Coresite Realty Corporation
COR
$901K 0.01%
8,417
+1,279
+18% +$127K
MGNX icon
573
MacroGenics
MGNX
$233M
$895K 0.01%
+49,761
New +$860K
EQC
574
DELISTED
Equity Commonwealth
EQC
$891K 0.01%
27,245
+3,978
+17% +$128K
FOX icon
575
Fox Class B
FOX
$22.1B
$890K 0.01%
+24,806
New +$945K

Similar funds

Rafferty Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Rafferty Asset Management held 873 positions worth $6.22B, up 36% from $4.58B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Rafferty Asset Management deployed $1.01B of net new capital in Q1 2019, opening 257 new positions and adding to 437 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 190,638 shares worth $30M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $127M trimmed.

  • Rafferty Asset Management's largest Q1 2019 buy was iShares Russell 1000 ETF: 190,638 shares worth $30M.
  • Rafferty Asset Management added most to iShares MSCI Brazil ETF in Q1 2019, an estimated $108M increase.
  • Rafferty Asset Management's biggest Q1 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $127M.
  • Rafferty Asset Management fully exited State Street SPDR S&P Oil & Gas Exploration & Production ETF in Q1 2019, selling an estimated $30.4M.
  • Rafferty Asset Management's ten largest holdings make up 51% of its $6.22B portfolio in Q1 2019.
  • Rafferty Asset Management opened 257 new positions and closed 84 in Q1 2019.
  • Rafferty Asset Management's portfolio value rose 36% quarter-over-quarter to $6.22B.

Based on Rafferty Asset Management's 13F filing for Q1 2019, filed 15 May 2019.